Impact of innate and adaptive immunity on rejection and tolerance

Transplantation

Volumn 86, Issue 7, 2008, Pages 889-894

  Kim, Irene K ^a   Bedi, Damanpreet Singh ^a   Denecke, Christian ^a   Ge, Xupeng ^a   Tullius, Stefan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adaptive immunity; Innate immunity; Rejection; Tolerance

Indexed keywords

CYCLOSPORIN A; ERYTHROPOIETIN; GAMMA INTERFERON; HEME OXYGENASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; SERINE PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION TOLERANCE; IMMUNITY; IMMUNOLOGY; REVIEW; T LYMPHOCYTE;

DENDRITIC CELLS; GRAFT REJECTION; HUMANS; IMMUNITY; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; TRANSPLANTATION TOLERANCE;

EID: 56049104474     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318186ac4a     Document Type: Article

References (70)

1. Terasaki PI, Cecka JM, Gjertson DW, et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
2. Medzhitov R, Janeway CA. Decoding the patterns of self and non-self by the innate immune system. Science 2002; 296: 298.
3. Pasare C, Medzhitov R. Toll-like receptors: Linking innate and adaptive immunity. Microbes Infect 2004; 6: 1382.
4. Garantziotis S, Palmer SM, Snyder LD, et al. Alloimmune lung injury induced by local innate immune activation through inhaled lipopoly-saccharide. Transplantation 2007; 84: 1012.
5. Matzinger P. The danger model: A renewed sense of self. Science 2002; 296: 301.
6. Paterson HM, Murphy TJ, Purcell EJ, et al. Injury primes the innate immune system for enhanced toll-like receptor reactivity. J Immunol 2003; 171: 1473.
7. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001; 166: 7128.
8. Andrade CF, Waddell TK, Keshavjee S, et al. Innate immunity and organ transplantation: The potential role of toll-like receptors. Am J Transplant 2005; 5: 969.
9. Tullius SG, Reutzel-Selke A, Egermann F, et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol 2000; 11: 1317.
10. Land WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005; 79: 505.
11. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
12. Zhai Y, Shen XD, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115.
13. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847.
14. Kaczorowski DJ, Nakao A, Mollen KP, et al. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 2007; 84: 1279.
15. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783.
16. Pratschke J, Wilhelm MJ, Laskowski I, et al. Influence of donor brain death on chronic rejection ofrenal transplants in rats.J Am Soc Nephrol 2001; 12: 2474.
17. Reutzel-Selke A, Filatenkov A, Jurisch A, et al. Grafts from elderly donors elicit a stronger immune response in the early period posttransplantation: A study in a rat model. Transplant Proc 2005; 37: 382.
18. van der Hoeven JA, Ploeg RJ, Postema F, et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: A model to study marginal organ donors. Transplantation 1999; 68: 1884.
19. Sánchez-Fructuoso A, Naranjo Garcia P, Calvo Romero N, et al. Effect of the brain-death process on acute rejection in renal transplantation. Transplantation Proc 2007; 39: 2214.
20. Schuurs TA, Morariu AM, Ottens PJ, et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006; 6: 2903.
21. Weiss S, Kotsch K, Francuski M, et al. Brain death activated donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007; 7: 1584.
22. van den Eijnden MM, Leuvenink HG, Ottens PJ, et al. Effect of brain death and non-heart-beating kidney donation on renal function and injury: An assessment in the isolated perfused rat kidney. Exp Clin Transplant 2003; 1: 85.
23. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405.
24. Kaminska D, Tyran B, Mazanowska O, et al. Cytokine gene expression in kidney allograft biopsies after donor brain death and ischemia-reperfusion injury usinginsitu reverse-transcription polymerase chain reaction analysis. Transplantation 2007; 84: 1118.
25. Reutzel-Selke A, Filatenkov A, Jurisch A, et al. Grafts from elderly donors elicit a stronger immune response in the early period posttransplantation: A study in a rat model. Transplant Proc 2005; 37: 382.
26. øien CM, Reisaeter AV, Leivestad T, et al. Living donor kidney transplantation: The effects of donor age and gender on short- and long-term outcomes. Transplantation 2007; 83: 600.
27. Reutzel-Selke A, Jurisch A, Denecke C, et al. Donor age intensifies the early immune response after transplantation. Kidney Int 2007; 71: 629.
28. Deng JF, Geng L, Qian YG, et al. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. Transplant Proc 2007; 39: 3222.
29. El Shikh ME, El Sayed RM, Wu Y, et al. TLR4 on follicular dendritic cells: An activation pathway that promotes accessory activity. J Immunol 2007; 179: 4444.
30. Schnare M, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947.
31. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033.
32. H1 priming. Nat Immunol 2004; 5: 1260.
33. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004; 5: 996.
34. Coulson MT, Jablonski P, Howden BO, et al. Beyond operational tolerance: Effect of ischemic injury on development of chronic damage in renal grafts. Transplantation 2005; 80: 353.
35. Uehara S, Chase CM, Colvin RB, et al. Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy. Transplant Proc 2005; 37: 70.
36. Huang Y, Rabb H, Womer KL. Ischemia reperfusion and immediate T cell responses. Cell Immunol 2007; 248: 4.
37. Kitchens WH, Uehara S, Chase CM, et al. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006; 81: 811.
38. -/- mice. Nat Med 2001; 7: 557.
39. Rossi M, Young JW. Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005; 175: 1373.
40. Rama I, Bruene B, Torras J, et al. Hypoxia stimulus: An adaptive immune response during dendritic cell maturation. Kidney Int 2008; 73: 816.
41. Ke B, Shen XD, Gao F, et al. The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses. Transplantation 2005; 79: 1078.
42. Zwacka RM, Zhang Y, Halldorson J, et al. CD4(+) T lymphocytes mediate ischemia reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279.
43. Reutzel-Selke A, Pratschke J, Martins PN, et al. Ischemic preconditioning produces systemic protective and adoptively transferable effects. Kidney Int 2008 [Epub ahead of print].
44. + regulatory T cells control innate immune reactivity after injury. J Immunol 2005; 174: 2957.
45. Burne-Taney MJ, Liu M, Baldwin WM, et al. Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 2006; 176: 7015.
46. Pascher A, Proesch S, Pratschke J, et al. Rat cytomegalovirus infection interferes with anti-CD4 mAb-(RIB 5/2) mediated tolerance and induces chronic allograft damage. Am J Transplant 2006; 6: 2035.
47. Wu Z, Bensinger SJ, Zhang J, et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004; 10: 87.
48. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632.
49. Yang J, Brook MO, Carvalho-Gaspar M, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 2007; 104: 19954.
50. Lu L, Thomson AW. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002; 73: S19.
51. Fu F, Li Y, Qian S, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allo- graft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659.
52. Wang Q, Zhang M, Ding G, et al. Anti-ICAM-1 antibody and CTLA-4Ig synergistically enhance immature dendritic cells to induce donor-specific immune tolerance in vivo. Immunol Lett 2003; 90: 33.
53. Zhai Y, Meng L, Gao F, et al. CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent. J Immunol 2006; 176: 5988.
54. Beilke JN, Kuhl NR, Van Kaer L, et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11: 1059.
55. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203: 1851.
56. LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007; 178:7503.
57. Matsuoka L, Shah T, Aswad S, et al. Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation. Am J Transplant 2006; 6: 1473.
58. Polyak MM, Arrington BO, Stubenbord WT, et al. The influence of pulsatile perfusion on renal transplantation in the 1990s. Transplantation 2000; 69: 249.
59. Schold JD, Kaplan B, Howard RJ, et al. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant 2005; 5: 1681.
60. Kwiatkowski A, Wszola M, Kosieradzki M, et al. Machine perfusion preservation improves renal allograft survival. Am J Transplant 2007; 7: 1942.
61. StrattaRJ, Moore PS, FarneyAC, et al. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg 2007; 204: 873.
62. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83: 1289.
63. Dutheil D, Rioja-Pastor I, Tallineau C, et al. Protective effect of PEG 35,000 Da on renal cells: Paradoxical activation of NK signaling pathway during cold storage. Am J Transplant 2006; 6: 1529.
64. Imamura R, Isaka Y, Ichimaru N, et al. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun 2007; 353: 786.
65. Imamura R, Moriyama T, Isaka Y, et al. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation 2007; 83: 1371.
66. Reutzel-Selke A, Zschockelt T, Denecke C, et al. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation 2003; 75: 1786.
67. Kotsch K, Francuski M, Pascher A, et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 2006; 6: 477.
68. Tullius SG, Nieminen-Kelhä M, Buelow R, et al. Inhibition of ischemia/ reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74:591.
69. Takahashi Y, Geller DA, Gambotto A, et al. Adenovirus-mediated gene therapy to liver grafts: Successful gene transfer by donor pretreatment. Surgery 2000; 128: 345.
70. Jiang J, Arp J, Kubelik D, et al. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment. Transplantation 2007; 84: 1158.